Understanding HIV burden and factors affecting HIV/AIDS in children and young adolescents
Quantification of HIV burden and the biomedical, structural, and behavioral factors influencing HIV/AIDS among children and young adolescents
This study is looking at how HIV/AIDS affects children and young teens, focusing on what helps or hinders their health, so we can find better ways to support them and improve their access to testing and treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11019706 on NIH RePORTER |
What this research studies
This research investigates the burden of HIV/AIDS among children and young adolescents, focusing on how biomedical, structural, and behavioral factors influence their health outcomes. The study aims to gather and analyze local data to better understand new HIV infections in these age groups, which are often overlooked in current estimates. By examining factors such as HIV testing rates and access to treatment, the research seeks to identify gaps in care and improve health strategies for affected populations. The findings could help inform public health initiatives aimed at reducing HIV transmission and improving treatment access for young individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and young adolescents aged 0-14 years who are living with or at risk for HIV/AIDS.
Not a fit: Patients who are older than 14 years or who do not have any risk factors for HIV/AIDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing and treating HIV/AIDS in children and young adolescents.
How similar studies have performed: Previous research has shown success in addressing HIV/AIDS in adult populations, but this specific focus on children and young adolescents is relatively novel.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Kyu, Hmwe Hmwe — University of Washington
- Study coordinator: Kyu, Hmwe Hmwe
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.